The three isoforms of transforming growth factor-β co-stimulate rat T cells and inhibit lymphocyte apoptosis

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 371-378

  Schiott A ^a   Sjogren H O ^a   Lindvall, M ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUTRALIZING ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; PROTEIN ISOFORMS; RATS; RATS, WISTAR; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031781378     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00405.x     Document Type: Article

References (62)

1. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological function and chemical structure. Science 1986;233:532-4.
2. Sporn MB, Roberts AB, Wakenfield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cellular Biol 1987;105:1039-45.
3. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988;332:217-9.
4. Massagué J. The TGF-β family of growth and differentiation factors. Cell 1987;49:437-8.
5. Van Obberghen Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta-1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-6.
6. Yamamoto H, Hirayama M, Genyea C, Kaplan J. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J Immunol 1994;152:3842-7.
7. Noble PW, Henson PM, Lucas C, Mora WM, Carre PC, Riches DWH. Transforming growth factor-beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine-paracrine mechanism. J Immunol 1993;151:979-89.
8. Sulitzeanu D. Immunosuppressive factors in human cancer. In: Vande Woude GF, Klein G, eds. Advances in Cancer Research, Vol. 60. San Diego: Academic Press, 1993:247-67.
9. Derynck R, Jarrett JA, Chen EY et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
10. Gamble JR, Khew G-Y, Vadas MA. Transforming growth factor-beta inhibits E selectin expression on human endothelial cells. J Immunol 1993;150:4494-503.
11. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta-1 beta-2 and beta-3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990;145:940-4.
12. Khalil N, O'Conner RN, Flanders KC, Unruh H. TGF-beta-1, but not TGF-beta-2 or TGF-beta-3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Resp Cell Mol Biol 1996;14:131-8.
13. Auvinen P, Lipponen P, Johansson R, Syrjanen K. Prognostic significance of TGF-beta-1 and TGF-beta-2 expressions in female breast cancer. Anticancer Res 1995;15:2627-31.
14. Frank S, Madlener M, Werner S. Transforming growth factors beta-1, beta-2, and beta-3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996;271:10188-93.
15. Kulkarni AB, Huh CG, Becker D et al. Transforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-4.
16. Bursch W, Oberhammer F, Jirtle RL et al. Transforming growth factor-beta-1 as a signal for induction of cell death by apoptosis. Br J Cancer 1993;67:531-6.
17. Oberhammer FA, Pavelka M, Sharma S et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta-1. Proc Natl Acad Sci USA 1992;89:5408-12.
18. Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Ichiyoshi Y, Sugimachi K. Transforming growth factor-beta-1 induces upoptosis in gastric cancer cells through a p53-independent pathway. Cancer 1996;77:1628-33.
19. Yanagihara K, Tsumuraya M. Transforming growth factor beta-1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992;52:4042-5.
20. Lin JK, Chou CK. In-vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β-1. Cancer Res 1992;52:385-8.
21. Weller M, Constam DB, Malipiero U, Fontana A. Transforming growth factor-beta-2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur J Immunol 1994;24:1293-300.
22. 2+ elevation and cyclosporin A synergistically induce TGF-β1-mediated apoptosis in lymphocytes. J Immunol 1997;158:2527-34.
23. Cerwenka A, Kovar H, Majdic O, Holter W. Fas-and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta-1. J Immunol 1996;156:459-64.
24. Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995;182:699-709.
25. +T lymphoblastoid cell line. Immunol Invest 1996;25:129-51.
26. Kawakami A, Eguchi K, Matsuoka N et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta-1. Arthritis Rheumatism 1996;39:1267-76.
27. Sachsenmeier KF, Sheibani N, Schlosser SJ, Allen H-BL. Transforming growth factor-beta-1 inhibits nucleosomal fragmentation in human keratinocytes following loss of adhesion. J Biol Chem 1996;271:5-8.
28. Bingisser R, Stey C, Weller M, Groscurth P, Russi E, Frei K. Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Resp Cell Mol Biol 1996;15: 64-70.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
30. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994;177:23-8.
31. Damle NK, Leytze G, Klussman K, Ledbetter JA. Activation with superantigens induces programmed death in antigen-primed CD4 positive class II positive major histocompatibility complex T lymphocytes via a CD11a-CD18-dependent mechanism. Eur J Immunol 1993;23:1513-22.
32. Kabelitz D, Wesselborg S. Life and death of a superantigen-reactive human CD4 positive T cell clone staphylococcal enterotoxins induce death by apoptosis but simultaneously trigger a proliferative response in the presence of HLA-DR plus antigen-presenting cells. Int Immunol 1992;4:1381-8.
33. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Van O-MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
34. Andree HAM, Teutelingsperger CPM, Hauptmann R. Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant α (VACα) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-8.
35. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-16.
36. Wyllie AH. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
37. Darzynkiewicz Z, Bruno S, Del Bino G et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
38. Telford WG, King LE, Fraker PJ. Comparative evaluation of several dna binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 1992;13:137-43.
39. Vermes I, Haanen C, Steffens N-H, Reutelingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
40. Kizaki H, Nakada SI, Ohnishi Y, Azuma Y, Mizuno Y, Tadakuma T. Tumour necrosis factor-alpha enhances cAMP-induced programmed cell death in mouse thymocytes. Cytokine 1993;5:342-7.
41. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 1994;84:2622-31.
42. Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor. J Immunol 1989;142:4295-300.
43. Ranges GE, Figari IS, Espevik T, Palladino MAJ. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 1987;166:991-8.
44. Bereta J, Bereta M, Coffman FD, Cohen S, Cohen MC. Inhibition of basal and tumor necrosis factor-enhanced binding of murine tumor cells to murine endothelium by transforming growth factor-beta. J Immunol 1992;148:2932-40.
45. + T lymphocytes. Int Immunol 1994;6:631-8.
46. Ravitz MJ, Yan S, Herr KD, Wenner CE. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27-Kip1 in C3H, 10T1-2 mouse fibroblasts. Cancer Res 1995;55:1413-6.
47. Cerwenka A, Bevec D, Majdic O, Knapp W, Wolfgang H. TGF-β is a potent inducer of human effector T cells. J Immunol 1994;153:4367-77.
48. Schiött Å, Sjögren HO, Lindvall M. Monocyte-dependent costimulatory effect of TGF-beta-1 on rat T-cell activation. Scand J Immunol 1996;44:252-60.
49. Lee HM, Rich S. Co-stimulation of T cell proliferation by transforming growth factor-beta-1. J Immunol 1991;147:1127-33.
50. Lee HM, Rich S. Differential activation of CD8 positive T cells by transforming growth factor-beta-1. J Immunol 1993;151:668-77.
51. + T cells. J Immunol 1995;155:609-18.
52. Nagelkerken L, Gollob KJ, Tielemans M, Coffman RL. Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B. Eur J Immunol 1993;23:2306-10.
53. Swain SL, Huston G. Tonkonogy S, Weinberg A. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147:2991-3000.
54. + T cell growth and apoptosis. J Immunol 1996; 157:2916-23.
55. Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997;89:910-8.
56. Riedl E, Strobl H, Majdic O, Knapp W. TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 1997;158:1591-7.
57. Chen RH, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science 1993;260:1335-8.
58. McCaffrey TA, Consigli S, Du B et al. Decreased type II-type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions: conversion from an antiproliferative to profibrotic response to TGF-beta-1. J Clin Invest 1995;96:2667-75.
59. Sankar S, Manhooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996;97:1436-46.
60. Chaouchi N, Arvanitakis L, Auffredou MT, Blanchard DA, Vazquez A, Sharma S. Characterization of transforming growth factor-beta-1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 1995;11:1615-22.
61. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 1995;155: 4926-32.
62. Maeda H, Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol 1996; 156:73-8.